Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Account Payables: 2020-2024

Historic Change in Account Payables for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$2.1 million.

  • Journey Medical's Change in Account Payables fell 262.86% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year increase of 70.51%. This contributed to the annual value of -$2.1 million for FY2024, which is 88.61% up from last year.
  • Per Journey Medical's latest filing, its Change in Account Payables stood at -$2.1 million for FY2024, which was up 88.61% from -$18.4 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Change in Account Payables peaked at $20.4 million during FY2021, and registered a low of -$18.4 million during FY2023.
  • Its 3-year average for Change in Account Payables is -$2.1 million, with a median of -$2.1 million in 2024.
  • In the last 5 years, Journey Medical's Change in Account Payables surged by 10,094.12% in 2021 and then crashed by 228.43% in 2023.
  • Journey Medical's Change in Account Payables (Yearly) stood at -$204,000 in 2020, then spiked by 10,094.12% to $20.4 million in 2021, then dropped by 29.65% to $14.3 million in 2022, then crashed by 228.43% to -$18.4 million in 2023, then skyrocketed by 88.61% to -$2.1 million in 2024.